News | September 22, 2011

AHA Survey Reveals Half of AFib Patients Unaware of Increased Stroke Risk

September 22, 2011 — Half the people who have atrial fibrillation deny or don’t know they have a higher risk for stroke, according to a new American Heart Association survey.

Atrial fibrillation, or AFib, is a quivering or irregular heartbeat that affects about 2.7 million Americans.

The most serious risk of AFib is the other conditions it can lead to, including stroke. Yet, in the association’s survey of 502 adults living with the condition, only 8 percent said stroke is their greatest health concern. Stroke is the No. 3 killer in America, behind heart disease and cancer.

“While there’s a lot known about atrial fibrillation, there’s a lot unknown as well,” said Mark Estes III, M.D., professor of medicine at Tufts University School of Medicine in Boston, Mass. “The American Heart Association’s goal for AFib is to bridge those knowledge gaps through research and education. By helping people better understand their risks, we can impact treatment and prevention of AFib and AFib-related strokes.”

Of those surveyed, half thought they were at risk for stroke; 25 percent said they weren’t at risk; and 25 percent did not know.

The survey also found that:

- Only two-thirds recalled that their healthcare provider talked with them about their elevated stroke risk.

- Among the 66 percent of AFib patients who talked with their doctors, 21 percent said they were told they have no stroke risk.

“Patients need to be aware of this risk and have serious conversations with their healthcare providers about what they should be doing to prevent stroke,” Estes said.

For more information:

Related Content

LivaNova Enters Binding Letter of Intent to Sell Cardiac Rhythm Management Business
News | EP Lab | January 26, 2018
January 26, 2018 — LivaNova PLC and MicroPort Scientific Corp.
Societies Detail Treatment for Patients With Ventricular Arrhythmias
News | EP Lab | October 30, 2017
The American College of Cardiology, along with the American Heart Association and the Heart Rhythm Society, published...
Baylis Medical and Siemens Co-Sponsor Transseptal Access Training Course
News | EP Lab | October 18, 2017
Baylis Medical Co. Inc. and Siemens Healthineers are co-sponsoring a first-of-its kind training program aimed at...
Spectranetics Initiates Class I Recall for Bridge Occlusion Balloon Catheter
News | EP Lab | September 27, 2017
Spectranetics is recalling its Bridge Occlusion Balloon Catheter due to the possibility of a blocked guidewire lumen in...
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab | September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices

Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices.

Feature | EP Lab | August 29, 2017 | Dave Fornell
August 29, 2017 — The U.S.
Ohio State Researchers Prove Human Heart's 'Battery' Has Multiple Backups
News | EP Lab | July 27, 2017
July 27, 2017 — There is good news when it comes to the heart’s sinoatrial node (SAN), the body’s natural...
Biosense webster multielectrode balloon RF ablation catheter

The Biosense Webster multi-electrode balloon RF ablation catheter. Each electrode can have varied power settings to avoid damage to underlying tissues like the esophagus. 

Feature | EP Lab | June 22, 2017 | Dave Fornell
Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve...
Videos | EP Lab | May 26, 2017
DAIC Editor Dave Fornell takes a tour of some of the most innovative new electrophysiology (EP) technology at the 201
Videos | EP Lab | May 17, 2017
This video, provided by Spectranetics, demonstrates how to deploy the Bridge Occlusion Balloon used to seal accidenta
Overlay Init